MISSISSAUGA, Ontario, April 15, 2026

Covalon Technologies Ltd. has reported a series of significant milestones across vascular access, infection prevention, and wound care, highlighting strong commercial momentum and growing clinical engagement. The company’s recent activities underscore its expanding presence in critical healthcare segments, driven by increasing demand for innovative, patient-focused medical technologies designed to address infection risks and improve clinical outcomes.

Strong Clinical Engagement at INS Annual Meeting

Covalon demonstrated a strong presence at the Infusion Nurses Society (INS) Annual Meeting, where its team engaged with clinicians from hospitals, clinics, and home infusion organizations, generating high-value discussions and new business opportunities. A key highlight was a presentation by vascular access expert Dr. Nancy Moureau, focusing on the critical issue of contamination in intravenous (IV) connections and access points. The session reinforced a growing industry concern around infection risks in vascular access, emphasizing the need for effective, purpose-built solutions. The strong response from clinicians reflects increasing awareness of contamination challenges and positions Covalon’s technologies as relevant and timely solutions in improving patient safety at the point-of-care.

Recognition at Major Infection Prevention Conferences

Building on this momentum, Covalon announced that the topic of IV line contamination and infection prevention has been selected for inclusion in upcoming major industry events, including the Association for Professionals in Infection Control and Epidemiology (APIC) Annual Conference and the Association for Vascular Access (AVA) Scientific Meeting. This recognition places Covalon at the center of global clinical education initiatives, validating its role as an emerging leader in infection prevention technologies. The company’s solutions, including VALGuard® Line Guard and CovaClear® IV Cover dressings, are gaining traction as healthcare systems prioritize reducing hospital-acquired infections and enhancing patient care standards. Increased educational exposure is expected to drive greater adoption of innovative MedTech solutions, further strengthening Covalon’s market position.

Advertisement

cGxPJobs Banner

Expanding Opportunities in Wound Care Innovation

Covalon also reported strong engagement at the Symposium on Advanced Wound Care (SAWC), where discussions with industry leaders and partners opened new collaboration and growth opportunities. The event enabled the company to reinforce its commercial relationships and explore strategic partnerships aimed at advancing its wound care portfolio. With a continued focus on innovation and clinical value, Covalon is actively evaluating opportunities to expand its footprint in wound care, aligning with its long-term strategy to deliver high-performance solutions that address unmet clinical needs. These developments reflect the company’s commitment to driving sustainable growth through innovation, partnerships, and market expansion.

As healthcare systems worldwide intensify efforts to combat infection risks and improve patient outcomes, Covalon’s advancements across vascular access, infection prevention, and wound care highlight its growing impact in the medical technology landscape. With strong clinical validation, increasing industry recognition, and expanding commercial opportunities, the company is well-positioned to capitalize on rising demand for advanced MedTech solutions that enhance safety and efficiency in patient care.

Source: Covalon Technologies press release